$86.88
al cierre: Nov 11 EDT
$87.98
1.101.27%
Pre-comercialización: 8:51 AM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Qorvo Inc tiene un precio objetivo de consenso de $99.22 basado en las calificaciones de 26 analistas. El máximo es $125, emitido por Piper Sandler el julio 30, 2025. El mínimo es $78, emitido por Goldman Sachs el enero 10, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Mizuho, JP Morgan y UBS el noviembre 11, 2025, noviembre 4, 2025 y octubre 29, 2025, respectivamente. Con un precio objetivo promedio de $102 entre Mizuho, JP Morgan y UBS, hay una 15.94% upside implícita para Qorvo Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Mizuho
JP Morgan
UBS
Citigroup
Loop Capital
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Qorvo
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/11/2025 | 5.71% | Mizuho | $75 → $93 | Upgrade | Underperform → Neutral | |||
11/04/2025 | 19.35% | JP Morgan | $92 → $105 | Upgrade | Underweight → Neutral | |||
10/29/2025 | 22.76% | UBS | $100 → $108 | Maintains | Neutral | |||
10/29/2025 | — | Benchmark | — | Downgrade | Buy → Hold | |||
10/29/2025 | 19.35% | Citigroup | $70 → $105 | Upgrade | Sell → Neutral | |||
10/28/2025 | — | Benchmark | — | Downgrade | Buy → Hold | |||
07/30/2025 | 2.3% | Loop Capital | $75 → $90 | Maintains | Hold | |||
07/30/2025 | 13.66% | UBS | $95 → $100 | Maintains | Neutral | |||
07/30/2025 | 2.3% | Barclays | $70 → $90 | Maintains | Equal-Weight | |||
07/30/2025 | 42.08% | Piper Sandler | $110 → $125 | Maintains | Overweight | |||
07/30/2025 | 0.02% | Stifel | $75 → $88 | Maintains | Hold | |||
07/30/2025 | 7.98% | Susquehanna | $90 → $95 | Maintains | Neutral | |||
07/30/2025 | 42.08% | Benchmark | $95 → $125 | Maintains | Buy | |||
07/30/2025 | 18.21% | Needham | $90 → $104 | Maintains | Buy | |||
07/22/2025 | 2.3% | Susquehanna | $75 → $90 | Maintains | Neutral | |||
07/21/2025 | 7.98% | UBS | $75 → $95 | Maintains | Neutral | |||
07/10/2025 | 2.3% | Goldman Sachs | → $90 | Initiates | → Neutral | |||
07/01/2025 | -4.52% | Mizuho | $75 → $84 | Maintains | Neutral | |||
06/27/2025 | 25.03% | Piper Sandler | $110 → $110 | Reiterates | Overweight → Overweight | |||
04/30/2025 | -20.44% | Barclays | $60 → $70 | Maintains | Equal-Weight | |||
04/30/2025 | -14.75% | Loop Capital | $90 → $75 | Maintains | Hold | |||
04/30/2025 | 7.98% | Benchmark | → $95 | Upgrade | Hold → Buy | |||
04/30/2025 | 2.3% | Needham | $100 → $90 | Maintains | Buy | |||
04/22/2025 | -31.8% | Barclays | $80 → $60 | Maintains | Equal-Weight | |||
01/29/2025 | 2.3% | Loop Capital | $80 → $90 | Maintains | Hold | |||
01/29/2025 | 2.3% | Stifel | $95 → $90 | Maintains | Hold | |||
01/29/2025 | — | Benchmark | — | Reiterates | Hold → Hold | |||
01/29/2025 | -21.57% | Citigroup | $72 → $69 | Maintains | Sell | |||
01/29/2025 | 13.66% | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
01/27/2025 | 25.03% | Piper Sandler | $85 → $110 | Upgrade | Neutral → Overweight | |||
01/24/2025 | 2.3% | Mizuho | $80 → $90 | Maintains | Neutral | |||
01/21/2025 | 20.48% | Morgan Stanley | $90 → $106 | Upgrade | Equal-Weight → Overweight | |||
01/17/2025 | -9.07% | Barclays | $90 → $80 | Maintains | Equal-Weight | |||
01/10/2025 | -11.34% | Goldman Sachs | $99 → $78 | Maintains | Neutral | |||
01/07/2025 | -9.07% | Mizuho | $98 → $80 | Maintains | Neutral | |||
11/11/2024 | -17.03% | Loop Capital | → $73 | Initiates | → Hold | |||
10/30/2024 | -3.39% | TD Cowen | $125 → $85 | Maintains | Hold | |||
10/30/2024 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/30/2024 | 2.3% | Barclays | $120 → $90 | Maintains | Equal-Weight | |||
10/30/2024 | 7.98% | JP Morgan | $115 → $95 | Maintains | Underweight | |||
10/30/2024 | -3.39% | Piper Sandler | $100 → $85 | Reiterates | Neutral → Neutral | |||
10/30/2024 | 2.3% | UBS | $115 → $90 | Maintains | Neutral | |||
10/30/2024 | 2.3% | Susquehanna | $115 → $90 | Maintains | Neutral | |||
10/30/2024 | 19.35% | Craig-Hallum | $142 → $105 | Maintains | Buy | |||
10/30/2024 | -9.07% | B of A Securities | $115 → $80 | Maintains | Underperform | |||
10/30/2024 | 13.66% | Needham | $135 → $100 | Maintains | Buy | |||
10/30/2024 | — | Benchmark | — | Downgrade | Buy → Hold | |||
10/30/2024 | -9.07% | Exane BNP Paribas | → $80 | Downgrade | Outperform → Neutral | |||
10/25/2024 | 13.66% | Piper Sandler | $120 → $100 | Maintains | Neutral | |||
10/21/2024 | 30.71% | Susquehanna | $135 → $115 | Maintains | Neutral | |||
10/11/2024 | 36.39% | Morgan Stanley | $130 → $120 | Downgrade | Overweight → Equal-Weight | |||
10/10/2024 | 36.39% | Barclays | $125 → $120 | Maintains | Equal-Weight | |||
07/31/2024 | 42.08% | TD Cowen | $110 → $125 | Maintains | Hold | |||
07/31/2024 | 30.71% | JP Morgan | $100 → $115 | Maintains | Underweight | |||
07/31/2024 | 53.44% | Raymond James | $115 → $135 | Maintains | Outperform | |||
07/31/2024 | 61.4% | Craig-Hallum | $125 → $142 | Maintains | Buy | |||
07/31/2024 | 34.12% | Goldman Sachs | $105 → $118 | Maintains | Neutral | |||
07/31/2024 | 36.39% | Rosenblatt | $105 → $120 | Maintains | Neutral | |||
07/31/2024 | 36.39% | Piper Sandler | $105 → $120 | Reiterates | Neutral → Neutral | |||
07/31/2024 | 53.44% | Susquehanna | $145 → $135 | Maintains | Neutral | |||
07/31/2024 | 53.44% | Needham | $110 → $135 | Maintains | Buy | |||
07/30/2024 | 42.08% | Barclays | $100 → $125 | Maintains | Equal-Weight | |||
07/17/2024 | 64.81% | Susquehanna | $95 → $145 | Maintains | Neutral | |||
06/12/2024 | 19.35% | Rosenblatt | $105 → $105 | Maintains | Neutral | |||
06/12/2024 | 25.03% | Needham | $110 → $110 | Reiterates | Buy → Buy | |||
05/03/2024 | 19.35% | Goldman Sachs | $117 → $105 | Maintains | Neutral | |||
05/02/2024 | 13.66% | Barclays | $110 → $100 | Maintains | Equal-Weight | |||
05/02/2024 | 13.66% | JP Morgan | $105 → $100 | Maintains | Underweight | |||
05/02/2024 | 45.49% | Benchmark | $136 → $128 | Maintains | Buy | |||
05/02/2024 | 7.98% | Susquehanna | $100 → $95 | Maintains | Neutral | |||
05/02/2024 | 19.35% | Mizuho | $115 → $105 | Maintains | Neutral | |||
05/02/2024 | 25.03% | Needham | $125 → $110 | Maintains | Buy | |||
04/08/2024 | 13.66% | Susquehanna | → $100 | Maintains | Neutral | |||
02/02/2024 | 32.98% | Goldman Sachs | $104 → $117 | Maintains | Neutral | |||
02/01/2024 | 42.08% | Needham | $125 → $125 | Reiterates | Buy → Buy | |||
02/01/2024 | 19.35% | Piper Sandler | $120 → $105 | Maintains | Neutral | |||
02/01/2024 | 19.35% | Rosenblatt | $95 → $105 | Maintains | Neutral | |||
02/01/2024 | 36.39% | Raymond James | $115 → $120 | Maintains | Outperform | |||
02/01/2024 | 19.35% | JP Morgan | $95 → $105 | Maintains | Underweight | |||
02/01/2024 | 32.98% | Goldman Sachs | $104 → $117 | Maintains | Neutral | |||
01/19/2024 | 30.71% | Raymond James | $105 → $115 | Maintains | Outperform | |||
01/16/2024 | 13.66% | Barclays | $95 → $100 | Maintains | Equal-Weight | |||
01/04/2024 | 36.39% | Piper Sandler | → $120 | Downgrade | Overweight → Neutral | |||
12/08/2023 | 52.31% | Morgan Stanley | $120 → $134 | Upgrade | Equal-Weight → Overweight | |||
11/03/2023 | 13.66% | BMO Capital | $110 → $100 | Maintains | Market Perform | |||
11/03/2023 | 10.25% | Mizuho | $107 → $97 | Maintains | Neutral | |||
11/02/2023 | 7.98% | JP Morgan | $110 → $95 | Maintains | Underweight | |||
11/02/2023 | 36.39% | Morgan Stanley | $116 → $120 | Maintains | Equal-Weight | |||
11/02/2023 | 19.35% | Raymond James | $125 → $105 | Maintains | Outperform | |||
11/02/2023 | 7.98% | Barclays | $110 → $95 | Maintains | Equal-Weight | |||
11/02/2023 | — | Summit Insights Group | — | Downgrade | Buy → Hold | |||
10/24/2023 | 7.98% | Susquehanna | $110 → $95 | Maintains | Neutral | |||
10/10/2023 | -11.34% | Citigroup | $116 → $78 | Downgrade | Neutral → Sell | |||
08/03/2023 | 42.08% | Raymond James | $120 → $125 | Maintains | Outperform | |||
08/03/2023 | 31.85% | Morgan Stanley | $111 → $116 | Maintains | Equal-Weight | |||
08/03/2023 | 25.03% | Wells Fargo | $100 → $110 | Maintains | Equal-Weight | |||
08/03/2023 | 25.03% | Susquehanna | $105 → $110 | Maintains | Neutral | |||
08/03/2023 | 7.98% | Rosenblatt | → $95 | Reiterates | Neutral → Neutral | |||
08/03/2023 | 42.08% | Needham | → $125 | Reiterates | Buy → Buy | |||
08/03/2023 | 53.44% | Exane BNP Paribas | → $135 | Upgrade | Neutral → Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Qorvo (QRVO)?
El último precio objetivo de Qorvo (NASDAQ:QRVO) fue comunicado por Mizuho el noviembre 11, 2025. La firma de analistas fijó un precio objetivo para $93.00 que espera QRVO a rise dentro de 12 meses (un posible 5.71% upside). 35 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Qorvo (QRVO)?
La última calificación de analistas para Qorvo (NASDAQ:QRVO) fue proporcionada por Mizuho, y Qorvo mejorado su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Qorvo (QRVO)?
La última revisión al alza de Qorvo Inc se produjo en noviembre 11, 2025, cuando Mizuho elevó su precio objetivo a $93. Mizuho anteriormente tenía an underperform para Qorvo Inc.
¿Cuándo fue la última revisión a la baja de Qorvo (QRVO)?
La última revisión a la baja de Qorvo Inc se produjo en octubre 29, 2025, cuando Benchmark cambió su precio objetivo de N/A a N/A para Qorvo Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Qorvo (QRVO)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Qorvo, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Qorvo se registró el noviembre 11, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 11, 2026.
¿Es correcta la calificación de los analistas sobre Qorvo (QRVO)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Qorvo (QRVO) fue un mejorado con un precio objetivo de $75.00 a $93.00. El precio actual al que cotiza Qorvo (QRVO) es de $87.98, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.